CS
HIMS icon

Credit Suisse’s Hims & Hers Health HIMS Stock Holding History

Credit Suisse’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.23M Buy
144,385
+11,947
+9% +$135K ﹤0.01% 1777
2023
Q4 		$1.18M Buy
132,438
+8,092
+7% +$59.8K ﹤0.01% 2234
2023
Q3 		$782K Sell
124,346
-3,912
-3% -$29.1K ﹤0.01% 2438
2023
Q2 		$1.21M Buy
128,258
+24,568
+24% +$244K ﹤0.01% 2260
2023
Q1 		$1.03M Buy
103,690
+2,281
+2% +$20K ﹤0.01% 2312
2022
Q4 		$650K Sell
101,409
-7,711
-7% -$43.9K ﹤0.01% 2615
2022
Q3 		$609K Sell
109,120
-105,433
-49% -$635K ﹤0.01% 2677
2022
Q2 		$972K Sell
214,553
-138,948
-39% -$593K ﹤0.01% 2405
2022
Q1 		$1.89M Sell
353,501
-182,495
-34% -$903K ﹤0.01% 2121
2021
Q4 		$3.51M Buy
535,996
+366,991
+217% +$2.65M ﹤0.01% 2317
2021
Q3 		$1.27M Buy
169,005
+35,295
+26% +$299K ﹤0.01% 3151
2021
Q2 		$1.43M Buy
+133,710
New +$1.59M ﹤0.01% 3116

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Credit Suisse's HIMS Position: Q1 2024 in Review

Credit Suisse increased its Hims & Hers Health (HIMS) stake by 9% in Q1 2024, buying an estimated $135K and bringing the position to 144,385 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Credit Suisse first reported a position in HIMS in Q2 2021 and has held it in 12 quarters since. The position peaked at $3.51M in Q4 2021. 244 funds tracked by Wall St. Rank hold HIMS as of Q1 2024.

  • Credit Suisse held 144,385 shares of Hims & Hers Health worth $2.23M as of Q1 2024.
  • Credit Suisse bought 11,947 Hims & Hers Health shares in Q1 2024, an estimated $135K.
  • Hims & Hers Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1777 holding.
  • Credit Suisse first reported a position in Hims & Hers Health in Q2 2021 and has held it in 12 quarters since.
  • Credit Suisse's Hims & Hers Health position peaked at $3.51M in Q4 2021.
  • 244 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.